Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Operating Expenses (2018 - 2026)

Updated

Precision Biosciences (DTIL) posted Operating Expenses of $19.16 million for fiscal Q2 2026 (quarter ended Jun 30, 2026), down 12.5% from $21.9 million a year earlier and down 3.8% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Operating Expenses (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Precision Biosciences was $81.45 million, down 10.9% year-over-year; for FY2025 (ended Dec 31, 2025), it came in at $86.41 million, down 8.9% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of -8.4% (FY2020 to FY2025).
  • In prior fiscal years, Precision Biosciences' Operating Expenses was $94.86 million in FY2024 (+2.6%), $92.46 million in FY2023 (+5.8%), $87.41 million in FY2022 (-43.6%) and $154.91 million in FY2021 (+15.5%).
  • The fiscal Q2 2026 figure stands as the lowest quarterly Operating Expenses since fiscal Q3 2018.
  • On a year-over-year basis, Operating Expenses has declined in each of the last five quarters, with an average decline of 6.8% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was fiscal Q4 2024, with growth of 16.2%; the weakest was fiscal Q4 2022, with a decline of 38.7%.
  • According to Business Quant data, Operating Expenses for the three prior fiscal quarters was $19.91 million (Q1 2026), $21.7 million (Q4 2025) and $20.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Precision Biosciences 165.47 Mn -183.71 Mn - 19.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.16 Mn
Mar 31, 2026 19.91 Mn
Dec 31, 2025 21.70 Mn
Sep 30, 2025 20.68 Mn
Jun 30, 2025 21.90 Mn
Mar 31, 2025 22.14 Mn
Dec 31, 2024 25.48 Mn
Sep 30, 2024 21.85 Mn
Jun 30, 2024 25.75 Mn
Mar 31, 2024 21.77 Mn
Dec 31, 2023 21.93 Mn
Sep 30, 2023 25.48 Mn
Jun 30, 2023 22.92 Mn
Mar 31, 2023 22.13 Mn
Dec 31, 2022 22.71 Mn
Sep 30, 2022 22.04 Mn
Jun 30, 2022 33.37 Mn
Mar 31, 2022 30.65 Mn
Dec 31, 2021 37.06 Mn
Sep 30, 2021 35.58 Mn
API Access

Precision Biosciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=DTIL&period=max&api_key=YOUR_API_KEY